Sanofi, Regeneron expand testing of potential coronavirus treatment
Sanofi and Regeneron Pharmaceuticals Inc have expanded a clinical trial of their rheumatoid arthritis drug Kevzara as a coronavirus treatment to patients outside the United States.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Arthritis | Clinical Trials | Coronavirus | COVID-19 | Health | Rheumatoid Arthritis | Rheumatology | USA Health